Geovax Labs (NASDAQ: GOVX)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-10 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.400 | -0.340 | 0.0600 | ||||
REV | 81.526K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Geovax Labs (NASDAQ: GOVX) through any online brokerage.
Other companies in Geovax Labs’s space includes: Panbela Therapeutics (NASDAQ:PBLA), Biocept (NASDAQ:BIOC), Cellectar Biosciences (NASDAQ:CLRB), Addex Therapeutics (NASDAQ:ADXN) and Brickell Biotech (NASDAQ:BBI).
The latest price target for Geovax Labs (NASDAQ: GOVX) was reported by Maxim Group on Monday, May 23, 2022. The analyst firm set a price target for 6.00 expecting GOVX to rise to within 12 months (a possible 140.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Geovax Labs (NASDAQ: GOVX) is $2.5 last updated Today at May 24, 2022, 6:56 PM UTC.
There are no upcoming dividends for Geovax Labs.
Geovax Labs’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for Geovax Labs.
Geovax Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.